Lilly’s Jaypirca shows positive results in phase 3 trial

12th August 2025 Uncategorised 0

Pirtobrutinib meets primary endpoint in CLL/SLL study

More: Lilly’s Jaypirca shows positive results in phase 3 trial
Source: News